Screener
Larimar Therapeutics LRMR Q4 2025 Annual earnings
Reported March 19, 2026 · Before market open
EPS-$0.73Miss by $0.29
EPS estimate-$0.44
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$0.39
Versus estimates
Diluted EPS
FAQ
- When did Larimar Therapeutics report Q4 2025 earnings?
- Larimar Therapeutics (LRMR) reported Q4 2025 earnings on March 19, 2026 before market open.
- What were Larimar Therapeutics's Q4 2025 revenue and EPS?
- Larimar Therapeutics reported eps of $-0.73 for Q4 2025.
- Did Larimar Therapeutics beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.44 by $0.29.
- How did Larimar Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 62.2% from $-0.45.
- Where can I find Larimar Therapeutics's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-115119) and the 10-K periodic report (0001193125-26-115878) directly on SEC EDGAR. The filing index links above go to sec.gov.
